Delta Asia International FCF Yield

What does Delta Asia International do? Delta Asia International Corp. generates revenue through the manufacture and sale of medical devices, including cardiovascular minimally invasive surgical equipment, abdominal cavity minimally invasive surgical equipment, disposable surgical robotic equipment, blood glucose monitoring portable devices, automated insulin delivery systems, physiological monitoring portable devices, safety syringes, and orthopedic surgical equipment. The company serves healthcare providers and medical institutions across the Americas and Asia, focusing on minimally invasive surgical solutions and portable monitoring devices. Its product portfolio targets hospitals, clinics, and specialized medical facilities seeking advanced, disposable, and automated surgical and monitoring technologies. The firm's revenue streams are derived from direct sales to these healthcare segments, emphasizing innovation in minimally invasive procedures and patient monitoring systems. The company's primary customers include hospitals, clinics, and medical facilities in the Americas and Asia, which purchase its cardiovascular, orthopedic, and disposable surgical equipment. Sales of blood glucose monitoring devices and automated insulin delivery systems cater to diabetes care providers and patients, while safety syringes are supplied to general healthcare institutions. Delta Asia International Corp. leverages its 134 full-time employees to support manufacturing and sales operations, ensuring product availability and technical support for its medical device solutions in key regional markets. Delta Asia International Corp. focuses on high-demand medical device segments such as cardiovascular and orthopedic surgical equipment, disposable robotic tools, and portable monitoring systems. Its products are designed for minimally invasive procedures, reducing patient recovery times and enhancing surgical precision. The company's revenue is driven by recurring demand for disposable surgical equipment and ongoing need for physiological monitoring devices, particularly in regions with growing healthcare infrastructure. Sales of automated insulin delivery systems target specialized diabetes management markets within its operational regions. Delta Asia International is one of the most popular companies on Eulerpool.